Letter: choosing between ustekinumab and vedolizumab in...

Alimentary Pharmacology & Therapeutics 2020 / 08 Vol. 52; Iss. 3

Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail. Authors' reply

Alric, Hadrien, Amiot, Aurélien, Carbonnel, Franck, Meyer, Antoine
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
52
Journal:
Alimentary Pharmacology & Therapeutics
DOI:
10.1111/apt.15888
Date:
August, 2020
File:
PDF, 258 KB
2020
Conversion to is in progress
Conversion to is failed